8-144415944-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_130849.4(SLC39A4):c.340G>A(p.Ala114Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.491 in 1,591,926 control chromosomes in the GnomAD database, including 195,443 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_130849.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC39A4 | NM_130849.4 | c.340G>A | p.Ala114Thr | missense_variant | 2/12 | ENST00000301305.8 | NP_570901.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC39A4 | ENST00000301305.8 | c.340G>A | p.Ala114Thr | missense_variant | 2/12 | 1 | NM_130849.4 | ENSP00000301305.4 | ||
SLC39A4 | ENST00000276833.9 | c.265G>A | p.Ala89Thr | missense_variant | 1/11 | 2 | ENSP00000276833.5 | |||
SLC39A4 | ENST00000526658.1 | c.193-525G>A | intron_variant | 3 | ENSP00000434512.1 |
Frequencies
GnomAD3 genomes AF: 0.439 AC: 66765AN: 151934Hom.: 15455 Cov.: 33
GnomAD3 exomes AF: 0.458 AC: 97205AN: 212328Hom.: 22840 AF XY: 0.464 AC XY: 53849AN XY: 116026
GnomAD4 exome AF: 0.496 AC: 714316AN: 1439874Hom.: 179990 Cov.: 87 AF XY: 0.494 AC XY: 353224AN XY: 714592
GnomAD4 genome AF: 0.439 AC: 66786AN: 152052Hom.: 15453 Cov.: 33 AF XY: 0.438 AC XY: 32592AN XY: 74336
ClinVar
Submissions by phenotype
Hereditary acrodermatitis enteropathica Benign:3
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 10, 2021 | - - |
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 09, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at